|
New
Drug May Extend Breast Cancer Treatment after Tamoxifen
Pomegrantes to the Rescue?
Isn't it wonderful?
Women who have had the required 5-year regimen of Tamoxifen will be able
to take a new drug to extend their protection. One question is--how does
the new drug work and another is--what are the side effects? Newspaper
reports say that the drug is an "aromatase inhibitor."
Fine. Now read
this--Aromatase is the enzyme that aids in the body's synthesis of
estrogen. So, estrogen being potentially carcinogenic, reducing women's
estrogen production should be helpful.
"The ability to effect a blockage of endogenous 'within the body] active
estrogen ...synthesis was shown by polyphenols from fermented
and 'unfermented]
pomegranate juice...and
oil, which
inhibited aromatase activity by 60-80%..."
Emphasis added.
By Kim, Mehta, Yu,
Neeman, Rabi, Poirier, Kaplan, Lansky, et al., Dept. of Pharmacy, Pusan
Nat. U., Korea. In Breast Cancer Res. Treat. vol. 27, 2002.
back
to Cancer index

TOP OF PAGE
SEARCH BY SUBJECT -
TABLE OF CONTENTS
THIS MONTH'S HEALTH
BULLETIN NEWS

If you
find Health Bulletin
interesting,
please click here to "Tell a Friend"


click here |